Zettlitz, K. A., Tavaré, R., Knowles, S. M., Steward, K. K., Timmerman, J. M., & Wu, A. M. (2017). ImmunoPET of malignant and normal B cells with (89)Zr- and (124)I-labeled obinutuzumab antibody fragments reveals differential CD20 internalization in vivo. Clin Cancer Res.
Citação norma ChicagoZettlitz, Kirstin A., Richard Tavaré, Scott M. Knowles, Kristopher K. Steward, John M. Timmerman, and Anna M. Wu. "ImmunoPET of Malignant and Normal B Cells With (89)Zr- and (124)I-labeled Obinutuzumab Antibody Fragments Reveals Differential CD20 Internalization in Vivo." Clin Cancer Res 2017.
MLA引文Zettlitz, Kirstin A., et al. "ImmunoPET of Malignant and Normal B Cells With (89)Zr- and (124)I-labeled Obinutuzumab Antibody Fragments Reveals Differential CD20 Internalization in Vivo." Clin Cancer Res 2017.